Brussels, 27 November 2024
The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control of Sylvan International Biotechnology Co Ltd (‘Sylvan’) of China by Novo Holdings of Denmark and KKR & Co. Inc. (‘KKR’) of the US.
The transaction relates primarily to the market for the development and production of spawn for edible mushrooms.
The Commission concluded that the notified transaction would not raise competition concerns, given that the joint venture has negligible activities in the European Economic Area, and the companies’ limited combined market position resulting from the proposed transaction. The notified transaction was examined under the simplified merger review procedure.
More information is available on the Commission’s competition website, in the public case register under the case number M.11703.